NC
Highly rated in
29
conditions

Dr. Naga P. Chalasani

Gastroenterology - North University
Indianapolis, IN
Highly rated in
29
conditions
Specialties:Gastroenterology
Experience:35 Years
Age:59
Clinical Trials:Currently Recruiting for 8 Trials
Accepts:New PatientsMedicare
Highly rated in
29
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Naga P. Chalasani's experience treating your condition:
About Dr. Naga P. Chalasani

Naga Chalasani is a Gastroenterologist in Indianapolis, Indiana. Chalasani has been practicing medicine for over 35 years and is highly rated in 29 conditions, according to our data. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Hepatitis, Liver Transplant, and Endoscopy. He is licensed to treat patients in Indiana. Chalasani is currently accepting new patients.

His clinical research consists of co-authoring 367 peer reviewed articles and participating in 19 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Naga P. Chalasani it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Naga P. Chalasani accepts the following insurance:

  •  Ambetter
  •  Anthem
  •  CareSource
  •  MHS
Call to see if your plan is accepted.
Locations
550 University Blvd, Suite 1710, Indianapolis, IN 46202
Other Locations
10300 N Illinois St, Suite 1100, Indianapolis, IN 46290
Background & Education
Graduate Institution
Other, 1988
Specialties
Gastroenterology
Licenses
Internal Medicine in IN
Hospital Affiliations
IU Health Methodist Hospital
Witham Health Services
IU Health North Hospital
Union Hospital
IU Health Blackford Hospital
Languages Spoken
English
Hindi
Telugu
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials
Alcoholic Hepatitis Network Observational Study
Enrollment Status: Recruiting
Publish Date: October 20, 2022
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk
Enrollment Status: Recruiting
Publish Date: June 01, 2022
Intervention Type: Device, Diagnostic Test
Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
Enrollment Status: Recruiting
Publish Date: April 12, 2022
Intervention Type: Drug
Study Phase: Not Applicable
Idiosyncratic Liver Injury Associated With Drugs (ILIAD): A Retrospective Study
Enrollment Status: Recruiting
Publish Date: April 27, 2022
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
Enrollment Status: Recruiting
Publish Date: October 06, 2022
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Enrollment Status: Recruiting
Publish Date: February 22, 2022
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Enrollment Status: Recruiting
Publish Date: October 07, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Multi-Center, Longitudinal Study of Drug-and CAM-Induced Liver Injury
Enrollment Status: Recruiting
Publish Date: April 27, 2022
The Effect of Vitamin E and Docosahexaenoic Acid Ethyl Ester on Non-Alcoholic Fatty Liver Disease (NAFLD) - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)
Enrollment Status: Completed
Publish Date: October 21, 2022
Intervention Type: Other, Dietary Supplement, Combination Product
Study Phase: Phase 2
Role of Exenatide in Treatment of NASH-a Pilot Study
Enrollment Status: Completed
Publish Date: April 11, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter Randomized, Double-Blind, Placebo-controlled, Dosing, Safety and Efficacy Study of IMM 124-E (Hyperimmune Bovine Colostrum) for Patients With Severe Alcoholic Hepatitis
Enrollment Status: Completed
Publish Date: January 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
2017-01: Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: August 06, 2020
Intervention Type: Other
A Multi-Center, Partially Blinded, Maximum Tolerated Multiple Dose Escalation, Phase 1 Clinical Trial to Evaluate the Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH)With Advanced Hepatic Fibrosis
Enrollment Status: Completed
Publish Date: February 23, 2015
Intervention Type: Drug
Study Phase: Phase 1
A Multicenter, Randomized, Double Blinded, Placebo-controlled Clinical Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis by the AlcHepNet Consortium
Enrollment Status: Completed
Publish Date: September 16, 2022
Intervention Type: Drug
Study Drugs: Anakinra and ZincPrednisone
Study Phase: Phase 2
The Early Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Due to Portal Hypertension
Enrollment Status: Completed
Publish Date: July 08, 2008
Intervention Type: Drug
Study Phase: Phase 3
Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Enrollment Status: Completed
Publish Date: February 23, 2022
A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)
Enrollment Status: Terminated
Publish Date: January 28, 2020
Intervention Type: Drug
Study Phase: Phase 2
Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium
Enrollment Status: Completed
Publish Date: February 11, 2020
View 10 Less Clinical Trials -
368 Total Publications
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury.
Journal: Journal of hepatology
Published: July 21, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
EF
Dr. Evan L. Fogel
Gastroenterology
Highly rated in
22
conditions
Gastroenterology

Indiana University Health

IU Health Physicians Gastroenterology

550 N University Blvd, 
Indianapolis, IN 
 0.1 mi

Evan Fogel is a Gastroenterologist in Indianapolis, Indiana. Fogel has been practicing medicine for over 32 years and is highly rated in 22 conditions, according to our data. His top areas of expertise are Sphincter of Oddi Dysfunction, Hereditary Pancreatitis, Chronic Pancreatitis, Endoscopy, and Stent Placement. He is licensed to treat patients in Indiana. Fogel is currently accepting new patients.

GL
Dr. Glen A. Lehman
Gastroenterology
Highly rated in
22
conditions
Gastroenterology

Indiana University Health

IU Health Physicians Gastroenterology

550 University Blvd, 
Indianapolis, IN 

Glen Lehman is a Gastroenterologist in Indianapolis, Indiana. Lehman has been practicing medicine for over 55 years and is highly rated in 22 conditions, according to our data. His top areas of expertise are Sphincter of Oddi Dysfunction, Pancreas Divisum, Chronic Pancreatitis, Endoscopy, and Stent Placement. He is licensed to treat patients in Indiana. Lehman is currently accepting new patients.

JW
Dr. John M. Wo
Gastroenterology
Highly rated in
25
conditions
Gastroenterology

Indiana University Health

IU Health Physicians Gastroenterology

550 N University Blvd, 
Indianapolis, IN 
 0.1 mi

John Wo is a Gastroenterologist in Indianapolis, Indiana. Wo has been practicing medicine for over 33 years and is highly rated in 25 conditions, according to our data. His top areas of expertise are Gastroparesis, Small Bowel Bacterial Overgrowth, Swallowing Difficulty, Gastrectomy, and Endoscopy. He is licensed to treat patients in Indiana and Kentucky. Wo is currently accepting new patients.